Neural Mechanisms of Salivary Gland SecretionS. Balkuv-Ulutin, T. Yardimci |
Contents
LMWH and Pregnancy 916 | 9 |
OCTOBER | 17 |
Methods to Monitor the Treatment | 47 |
Copyright | |
10 other sections not shown
Common terms and phrases
abnormalities activated protein acute agents allele anti-Xa antibodies anticoagulant therapy antigen antiphospholipid antithrombotic APC resistance APC-R APTT argatroban assay atherosclerosis ATIII bleeding cardiovascular cells Center clinical clotting collagen complex complications concentration control group coronary D-dimer decreased deep vein thrombosis deficiency Department diabetes diagnosis disease disorders dosage dose drugs effect endothelial erythrocyte evaluated factor V Leiden factor VIII factor Xa fibrin fibrinogen fibrinolytic FV Leiden gene genetic Hematology hemophilia hemostasis heparin heterozygous hirudin Hospital increased inhibition inhibitors interaction investigated Istanbul laboratory Leiden mutation levels LMWH Medical Medicine method molecular weight heparins myocardial infarction normal oral anticoagulant parameters patients plasma plasminogen activator platelet platelet activation platelet aggregation platelet count pregnancy present prophylaxis prothrombin pulmonary embolism receptor recurrent risk factors significant significantly surgery syndrome TFPI therapeutic thrombin thrombocytopenia thrombolytic thrombophilia thrombotic thrombus tissue factor treatment University vascular venous thromboembolism venous thrombosis warfarin